{"id":6475,"date":"2016-01-19T00:00:00","date_gmt":"2016-01-19T05:00:00","guid":{"rendered":"https:\/\/icesontario.wpengine.com\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/"},"modified":"2023-06-14T20:12:18","modified_gmt":"2023-06-15T00:12:18","slug":"comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries","status":"publish","type":"journal_article","link":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/","title":{"rendered":"Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries"},"content":{"rendered":"

Importance<\/strong> — Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest.<\/p>\n

Objective<\/strong> — To compare site of death, healthcare utilization, and hospital expenditures in 7 countries: Belgium, Canada, England, Germany, the Netherlands, Norway, and the United States.<\/p>\n

Design, Setting and Participants<\/span> — Retrospective cohort study using administrative and registry data from 2010. Participants were decedents older than 65 years who died with cancer. Secondary analyses included decedents of any age, decedents older than 65 years with lung cancer, and decedents older than 65 years in the United States and Germany from 2012.<\/p>\n

Main Outcomes and Measures<\/span> — Deaths in acute care hospitals, 3 inpatient measures (hospitalizations in acute care hospitals, admissions to intensive care units, and emergency department visits), 1 outpatient measure (chemotherapy episodes), and hospital expenditures paid by insurers (commercial or governmental) during the 180-day and 30-day periods before death. Expenditures were derived from country-specific methods for costing inpatient services.<\/p>\n

Results<\/strong> — The United States (cohort of decedents aged >65 years, N = 211 816) and the Netherlands (N = 7216) had the lowest proportion of decedents die in acute care hospitals (22.2.% and 29.4%, respectively). A higher proportion of decedents died in acute care hospitals in Belgium (N = 21 054; 51.2%), Canada (N = 20 818; 52.1%), England (N = 97 099; 41.7%), Germany (N = 24 434; 38.3%), and Norway (N = 6636; 44.7%). In the last 180 days of life, 40.3%of US decedents had an intensive care unit admission compared with less than 18%in other reporting nations. In the last 180 days of life, mean per capita hospital expenditures were higher in Canada (US $21 840), Norway (US $19 783), and the United States (US $18 500), intermediate in Germany (US $16 221) and Belgium (US $15 699), and lower in the Netherlands (US $10 936) and England (US $9342). Secondary analyses showed
\nsimilar results.<\/p>\n

Conclusions and Relevance<\/span> — Among patients older than 65 years who died with cancer in 7 developed countries in 2010, end-of-life care was more hospital-centric in Belgium, Canada, England, Germany, and Norway than in the Netherlands or the United States. Hospital expenditures near the end of life were higher in the United States, Norway, and Canada, intermediate in Germany and Belgium, and lower in the Netherlands and England. However, intensive care unit admissions were more than twice as common in the United States as in other countries.<\/p>\n","protected":false},"excerpt":{"rendered":"

Importance — Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest. Objective — To compare site of death, healthcare utilization, and hospital expenditures in 7 countries: Belgium, Canada, England, Germany, the Netherlands, Norway, and the United States. Design, Setting and Participants — Retrospective cohort study using administrative and […]<\/p>\n","protected":false},"template":"","migration-helper-automated":[],"migration-manual":[],"topic":[38,33,61],"migration-helper-qa-sample-set":[],"class_list":["post-6475","journal_article","type-journal_article","status-publish","hentry","topic-cancer-and-cancer-screening","topic-end-of-life-care","topic-health-economics"],"acf":{"citation":"Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ, for the International Consortium for End-of-Life Research (ICELR). JAMA<\/em>. 2016; 315(3):272-83. Epub 2016 Jan 19.","source_url":"http:\/\/jama.jamanetwork.com\/article.aspx?articleid=2482325","ices_scientist":[1234,1128],"site":[6733],"research_program":[6740],"news_release":[7662],"journal_article":[],"atlas":[],"research_report":[],"infographic":[],"video":[],"downloads":null,"links":null,"sitecore_item_id":"7AD68CF4-1294-41DC-B89E-F5EE1B6FC89E","sitecore_item_name":"Comparison-of-site-of-death-healthcare-expenditures-for-cancer-deaths-in-developed-countries","sitecore_field_values":"{\n \"Title\": \"Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries\",\n \"Summary\": \"The researchers compared site of death, healthcare utilization, and hospital expenditures in 7 countries: Belgium, Canada, England, Germany, the Netherlands, Norway, and the United States.\",\n \"Citation\": \"

Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ, for the International Consortium for End-of-Life Research (ICELR). JAMA<\/em>. 2016; 315(3):272-83. Epub 2016 Jan 19.<\/p>\",\n \"Abstract\": \"

Importance<\/strong> — Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest.<\/p>rn

Objective<\/strong> — To compare site of death, healthcare utilization, and hospital expenditures in 7 countries: Belgium, Canada, England, Germany, the Netherlands, Norway, and the United States.<\/p>rn

Design, Setting and Participants<\/span> — Retrospective cohort study using administrative and registry data from 2010. Participants were decedents older than 65 years who died with cancer. Secondary analyses included decedents of any age, decedents older than 65 years with lung cancer, and decedents older than 65 years in the United States and Germany from 2012.<\/p>rn

Main Outcomes and Measures<\/span> — Deaths in acute care hospitals, 3 inpatient measures (hospitalizations in acute care hospitals, admissions to intensive care units, and emergency department visits), 1 outpatient measure (chemotherapy episodes), and hospital expenditures paid by insurers (commercial or governmental) during the 180-day and 30-day periods before death. Expenditures were derived from country-specific methods for costing inpatient services.<\/p>rn

Results<\/strong> — The United States (cohort of decedents aged >65 years, N = 211 816) and the Netherlands (N = 7216) had the lowest proportion of decedents die in acute care hospitals (22.2.% and 29.4%, respectively). A higher proportion of decedents died in acute care hospitals in Belgium (N = 21 054; 51.2%), Canada (N = 20 818; 52.1%), England (N = 97 099; 41.7%), Germany (N = 24 434; 38.3%), and Norway (N = 6636; 44.7%). In the last 180 days of life, 40.3%of US decedents had an intensive care unit admission compared with less than 18%in other reporting nations. In the last 180 days of life, mean per capita hospital expenditures were higher in Canada (US $21 840), Norway (US $19 783), and the United States (US $18 500), intermediate in Germany (US $16 221) and Belgium (US $15 699), and lower in the Netherlands (US $10 936) and England (US $9342). Secondary analyses showed
rnsimilar results.<\/p>rn

Conclusions and Relevance<\/span> — Among patients older than 65 years who died with cancer in 7 developed countries in 2010, end-of-life care was more hospital-centric in Belgium, Canada, England, Germany, and Norway than in the Netherlands or the United States. Hospital expenditures near the end of life were higher in the United States, Norway, and Canada, intermediate in Germany and Belgium, and lower in the Netherlands and England. However, intensive care unit admissions were more than twice as common in the United States as in other countries.<\/p>rn

View full text<\/a><\/p>\",\n \"Keywords\": \"{5B386094-8417-4B93-9D08-2F46BC0458AB}|{4F321D0E-F7F1-4C8D-B2FE-922AD8DE3C78}|{6F47479A-93B4-40A0-A72C-7D6B55EEC91A}\",\n \"Related Products\": \"

NEWS RELEASE<\/h2>rn

High end-of-life cancer hospitalization rates, care costs in Canada: study<\/a><\/h3>rn

ICES IN THE NEWS<\/h2>rn

End-of-life care in Canada more hospital-centric than in U.S., Europe <\/a><\/h3>\",\n \"Research Programs\": \"{46DF28D2-EDE8-4DF2-8CC0-87CEF464E435}\",\n \"ICES Locations\": \"{4FCAABBA-14A5-42E6-8F33-BC6C2F1D9908}\",\n \"ICES Scientists\": \"{C34115AC-9191-4249-9796-3B20B060CFE7}|{C896C802-59A9-4EBD-9C51-CC7C3D35313F}\",\n \"Posted Date\": \"20160119T103900\",\n \"Show on Publications Landing Page\": \"1\"\n}","previous_url":"https:\/\/www.ices.on.ca\/Publications\/Journal-Articles\/2016\/January\/Comparison-of-site-of-death-healthcare-expenditures-for-cancer-deaths-in-developed-countries"},"yoast_head":"\nICES | Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries<\/title>\n<meta name=\"description\" content=\"Importance — Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICES | Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries\" \/>\n<meta property=\"og:description\" content=\"Importance — Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-15T00:12:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\\\/\",\"name\":\"ICES | Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2016-01-19T05:00:00+00:00\",\"dateModified\":\"2023-06-15T00:12:18+00:00\",\"description\":\"Importance — Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal Articles\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/publications\\\/journal-articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICES | Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries","description":"Importance — Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/","og_locale":"fr_FR","og_type":"article","og_title":"ICES | Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries","og_description":"Importance — Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest.","og_url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2023-06-15T00:12:18+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/","url":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/","name":"ICES | Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2016-01-19T05:00:00+00:00","dateModified":"2023-06-15T00:12:18+00:00","description":"Importance — Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest.","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/comparison-of-site-of-death-healthcare-utilization-and-hospital-expenditures-for-patients-dying-with-cancer-in-seven-developed-countries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Journal Articles","item":"https:\/\/www.ices.on.ca\/fr\/publications\/journal-articles\/"},{"@type":"ListItem","position":3,"name":"Comparison of site of death, healthcare utilization, and hospital expenditures for patients dying with cancer in seven developed countries"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article\/6475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/journal_article"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/journal_article"}],"acf:post":[{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/news_release\/7662"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/research_program\/6740"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/site\/6733"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1128"},{"embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/ices_scientist\/1234"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=6475"}],"wp:term":[{"taxonomy":"migration-helper-automated","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-automated?post=6475"},{"taxonomy":"migration-manual","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-manual?post=6475"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/topic?post=6475"},{"taxonomy":"migration-helper-qa-sample-set","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/migration-helper-qa-sample-set?post=6475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}